References
- Bhushan , R. and Parshad , V. 1996 . Resolution of (±) ibuprofen using L‐arginine‐impregnated thin layer chromatography . J. Chromatogr. A , 721 : 369 – 372 .
- Sajewicz , M. , Piętka , R. and Kowalska , T. 2004 . Chiral separation of S‐(+)‐ and R‐(−)‐ibuprofen by thin‐layer chromatography. An improved analytical procedure . J. Planar Chromatogr.‐Mod. TLC , 17 : 173 – 176 .
- Sajewicz , M. , Piętka , R. , Pieniak , A. and Kowalska , T. 2005 . Application of thin‐layer chromatography (TLC) to investigating oscillatory instability of the selected profen enantiomers . Acta Chromatogr. , 15 : 131 – 149 .
- Sajewicz , M. , Piętka , R. , Pieniak , A. and Kowalska , T. 2005 . Application of thin‐layer chromatography (TLC) to investigating oscillatory instability of the selected profen enantiomers in dichloromethane . J. Chromatogr. Sci. , 43 : 542 – 548 .
- Xie , Y. , Liu , H. and Chen , J. 2000 . Kinetics of base catalyzed racemization of ibuprofen enantiomers . Int. J. Pharm. , 196 : 21 – 26 .
- Yamamoto , K. , Ueno , Y. , Otsubo , K. , Kawakami , K. and Komatsu , K. 1990 . Production of S‐(+)‐ibuprofen from a nitrile compound by Acinetobacter sp. strain AK226 . Appl. Environ. Microbiol. , 56 : 3125 – 3129 .
- Neupert , W. , Brugger , R. , Euchenhofer , C. , Brune , K. and Geisslinger , G. 1997 . Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases . Brit. J. Pharmacol. , 122 : 487 – 492 .
- Landoni , M. F. and Soraci , S. 2001 . Pharmacology of chiral compounds: 2‐Arylpropionic acid derivatives . Curr. Drug Metab. , 2 : 37 – 51 .
- Davies , N. M. , Wright , M. R. , A.S.Russell , A.S. and Jamali , F. 1996 . Effect of the enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability . J. Pharm. Sci. , 85 : 1170 – 1173 .
- Janjikhel , R. K. , Bricker , J. D. , Borochovitz , D. and Adeyeye , C. M. 1999 . Stereoselective disposition of sustained release microspheres of ibuprofen enantiomers in rats: II . Acute gastrointestinal toxicity. Drug Deliv. , 6 : 163 – 170 .